biote vs Natural Alternatives International
BTMD and NAII side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BTMD and NAII compare
biote is the larger company, worth 1.8 times as much as Natural Alternatives International ($38.3M against $21.4M).
Natural Alternatives International grew revenue faster over the last twelve months (−1.1% versus −8.6% for biote).
biote keeps more of each dollar of sales as profit, with a net margin of −1.1% compared with −17.2% at Natural Alternatives International.
Natural Alternatives International scores higher on the StockData Score (8 against 4 for biote), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BTMD | NAII |
|---|---|---|
| Size and price | ||
| Market cap | $38.3M | $21.4M |
| Share price | $1.06 | $0.967 |
| Change, 1 year | −59.7% | −65.6% |
| Change, 5 years | −89.1% | −92.9% |
| Beta (5Y) | 0.51 | 0.18 |
| Employees | 223 | 219 |
| StockData Score | ||
| Total score | 4 | 8 (better) |
| Valuation score | 1 | 1 |
| Growth score | 0 | 0 |
| Performance score | 2 | 2 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.2× | 0.2× (better) |
| P/B | – | 0.5× |
| EV/EBITDA | 12.2× | – |
| P/FCF | 5.2× | – |
| FCF yield | 19.4% (better) | −31.0% |
| Growth | ||
| Revenue growth (TTM) | −8.6% | −1.1% (better) |
| Revenue growth, 5Y average | – | −4.4% |
| Net income growth (TTM) | −107% | – |
| EPS growth (TTM) | −114% | – |
| Profitability | ||
| Gross margin | 67.5% (better) | 4.4% |
| Operating margin | 5.0% (better) | −16.3% |
| Net margin | −1.1% (better) | −17.2% |
| FCF margin | 4.1% (better) | −5.0% |
| Return on equity | – | −39.4% |
| Return on invested capital | 18.5% (better) | −30.9% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Net debt / EBITDA | 8.62 | – |
| Current ratio | 1.37 | 1.37 (better) |
| Altman Z-score | 1.65 (better) | 1.32 |
| Piotroski F-score | 6 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | 18.9% (better) | 0.41% |
| Shareholder yield | 18.9% (better) | 0.41% |
| Ownership | ||
| Held by institutions | 36.6% | 10.5% |
| Held by insiders | 23.3% | 5.0% |
| Insider net buying, 12 months | $202K (better) | $26.8K |
| Short interest, % of float | 3.1% | 0.03% |
Go deeper
- BTMD stock overview
- BTMD income statement
- BTMD valuation and score
- NAII stock overview
- NAII income statement
- NAII valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.